DUBAI, United Arab Emirates – Recently, Arab Health 2024 was successfully held in Dubai. Shanghai MicroPort EP MedTech Co., Ltd. (referred to as "MicroPort EP") actively participated in the exhibition with a number of new products, showing a new picture of arrhythmia diagnosis and treatment in an all-round way.

Arab Health 2024 is an international professional medical equipment exhibition with the largest exhibition scale, complete exhibits and good exhibition effect in the Middle East. It is also one of the largest and professional comprehensive medical equipment exhibitions in the world and has considerable influence in the industry. During the exhibition, MicroPort EP exhibited a number of innovative products in the field of electrophysiological interventional diagnosis and ablation therapy, includes the latest Generation Columbus™ 3D EP Navigation System ( "Columbus™ System"), FireMagic™ TrueForce™ Ablation Catheter (referred to as "TrueForce™ Ablation Catheter"), EasyStars™ High Density Mapping Catheter (referred to as "EasyStars™ Catheter"), etc.

MicroPort EP has attracted numerous medical institution managers, distributors and experts from more than 30 countries, including the United States, Britain, Germany, Italy, South Korea, Turkey, the United Arab Emirates and Brazil. They exchanged views on the latest products and technology applications of MicroPort EP at the booth.

The precise navigation and efficient modeling functions of The Latest Generation Columbus™ System were demonstrated at the exhibition site, which attracted wide attention from experts attending the exhibition. As a pioneer of 3D surgery in the field of electrophysiology in China, MicroPort EP has been aiming at the technical bottleneck of 3D surgery since its inception, constantly breaking through. Up to now, Columbus™ System has completed more than 50000 cases of arrhythmia treatment, ranking first among domestic manufacturers.

TrueForce™ Ablation Catheter, as the first domestic developed and manufactured pressure monitoring catheter, has served more than 1000 patients since its launch, constantly refreshing the record of 3D cardiac electrophysiological procedures and has completed the first batch of clinical applications in Turkey, Spain, Poland, Greece and other countries. The catheter can be used in conjunction with the Columbus™ System to help physicians predict the depth of ablation lesions in real time by Energy Index, providing accurate ablation point for the operator during procedure. After the simulation trial, many experts said that TrueForce™ Ablation Catheter can monitor small contact force changes with high precision, and the force feedback is real-time, accurate and stable. At the same time, the handle is comfortable and easy to hold, which can effectively improve the efficacy and safety.

In addition, EasyStars™ Catheter has attracted many experts. The catheter features precise electrode spacing and small electrodes, which can obtain ECG signals, achieve high-density mapping, and help physicians better mapping ablation points, which has won unanimous recognition and praise from foreign experts.

For now, MicroPort EP's products have been exported to more than thirty countries and regions. In the future, MicroPort EP will actively expand its global reach, providing more comprehensive products and professional services to patients and physicians, offering a globally competitive integrated solution for electrophysiology intervention diagnosis and treatment.